4//SEC Filing
HOLUBIAK MYRON Z 4
Accession 0001213900-24-082813
CIK 0001506251other
Filed
Sep 26, 8:00 PM ET
Accepted
Sep 27, 5:27 PM ET
Size
30.3 KB
Accession
0001213900-24-082813
Insider Transaction Report
Form 4
HOLUBIAK MYRON Z
DirectorVice Chairman
Transactions
- Award
Warrant to Purchase Common Stock
2024-08-14+784,314→ 784,314 totalExercise: $1.15Exp: 2025-08-14→ Common Stock (784,314 underlying) - Award
Warrant to Purchase Common Stock
2024-09-25+558,597→ 558,597 totalExercise: $0.77Exp: 2025-09-27→ Common Stock (558,597 underlying) - Disposition to Issuer
Warrant to Purchase Common Stock
2024-08-14−784,314→ 0 totalExercise: $1.15Exp: 2024-08-14→ Common Stock (784,314 underlying) - Disposition to Issuer
Warrant to Purchase Common Stock
2024-09-25−558,597→ 0 totalExercise: $0.77Exp: 2024-09-27→ Common Stock (558,597 underlying)
Holdings
- 400,000
Stock Option (Right to Purchase Common Stock)
Exercise: $0.70Exp: 2033-10-10→ Common Stock (400,000 underlying) - 10,000(indirect: See footnote)
Stock Option (Right to Purchase Common Stock)
Exercise: $2.00Exp: 2031-07-22→ Common Stock (10,000 underlying) - 150,000
Stock Option (Right to Purchase Common Stock)
Exercise: $1.62Exp: 2028-09-04→ Common Stock (150,000 underlying) - 300,000
Stock Option (Right to Purchase Common Stock)
Exercise: $2.00Exp: 2031-07-22→ Common Stock (300,000 underlying) - 26,667
Stock Option (Right to Purchase Common Stock)
Exercise: $8.10Exp: 2025-10-01→ Common Stock (26,667 underlying) - 15,000(indirect: See footnote)
Stock Option (Right to Purchase Common Stock)
Exercise: $2.04Exp: 2031-10-11→ Common Stock (15,000 underlying) - 650,000
Stock Option (Right to Purchase Common Stock)
Exercise: $2.04Exp: 2031-10-11→ Common Stock (650,000 underlying) - 1,992,243
Common Stock
- 129,450
Warrant to Purchase Common Stock
Exercise: $1.42Exp: 2025-04-05→ Common Stock (129,450 underlying) - 400,000
Stock Option (Right to Purchase Common Stock)
Exercise: $1.25Exp: 2032-10-04→ Common Stock (400,000 underlying) - 175,000
Stock Option (Right to Purchase Common Stock)
Exercise: $0.67Exp: 2029-10-08→ Common Stock (175,000 underlying) - 200,000
Stock Option (Right to Purchase Common Stock)
Exercise: $1.01Exp: 2030-10-06→ Common Stock (200,000 underlying) - 40,000
Stock Option (Right to Purchase Common Stock)
Exercise: $3.45Exp: 2027-09-13→ Common Stock (40,000 underlying)
Footnotes (9)
- [F1]The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately.
- [F2]The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately.
- [F3]The warrant is fully vested and exercisable immediately.
- [F4]The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
- [F5]The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
- [F6]The options were granted on October 11, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
- [F7]The options are held by the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares.
- [F8]The options were granted on July 22, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
- [F9]The options are vested in full and exercisable immediately.
Documents
Issuer
Citius Pharmaceuticals, Inc.
CIK 0001506251
Entity typeother
Related Parties
1- filerCIK 0001199080
Filing Metadata
- Form type
- 4
- Filed
- Sep 26, 8:00 PM ET
- Accepted
- Sep 27, 5:27 PM ET
- Size
- 30.3 KB